We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
A picture of Alexander Beadle

Alexander Beadle profile page

Science Writer & Editor

 at Technology Networks


Alexander is a science writer and editor for Technology Networks. He writes news and features for the Applied Sciences section, leading the site's coverage of topics relating to materials science and engineering.

Before joining Technology Networks in 2023, Alexander worked as a freelance science writer, reporting on a broad range of topics including cannabis science and policy, psychedelic drug research and environmental science. He holds a masters degree in Materials Chemistry from the University of St Andrews, Scotland.


Education


University of St Andrews  


Awards & Certifications


Chemistry Purdie scholarship awarded by the University of St Andrews · August 2013


Areas of Expertise



Got a Question for Alexander Beadle?


Get in touch using the contact form linked here and we’ll get back to you shortly



Published Content
Total: 236
Article

A Look Inside the Massachusetts Cannabis Testing Controversy

Two cannabis testing facilities have now been issued provisional licenses in the state but the debate over their differing approaches to microbiological contamination testing continues.
Article

The Agricultural Perspective on Water Contamination by Pharmaceuticals

Despite centuries of research into drug development, investigation into the environmental impact of pharmaceuticals is a much younger field. If not treated effectively, there is the potential for pharmaceuticals in wastewater to affect the agricultural industry through the use of this contaminated water supply.
Article

Israeli Firm Commercializes Cannabis Testing “Lab-on-a-desk”

The analyzer is a hybrid testing machine which combines the use of near-infrared spectroscopy technology with visual image analysis and machine learning to accurately characterize the potency of a cannabis sample.
Article

Cannabis Genome Mapping Beats Human Genome Project Benchmark

A team at Medicinal Genomics have successfully sequenced the cannabis genome at 640kb N50, representing a 28% improvement on the Human Genome Project standard.
Article

Washington State Prepares for Cannabis Testing and Packaging Law Reform

A list of the proposed rule changes is expected to be published on or after October 31 2018 and will address issues like THC serving limits, packaging requirements, and contaminant testing.
Article

First Ever Cannabis Product Recalls Announced in California

The first voluntary product recall in California was initiated by the vape cartridge manufacturer, The Bloom Brand, on July 25 and the second by Lowell Herb Co. concerning a batch of their pre-rolled cannabis cigarettes.
Article

Combining CBD with Chemotherapy Posts Promising Results in Pancreatic Cancer Model

Mice who received a combination of CBD and chemotherapy survived nearly three times as long as the mice given the placebo, and around twice as long as the mice given CBD or chemotherapy alone.

Article

Variable Accumulation of Bioactive Metabolites Revealed in Medicinal Cannabis

Across four distinct strains it was observed that the flower samples taken from the upper third of the plant had a higher THC content than those at the base of the plant, and in two of the strains tested the difference was equivalent to the upper flowers being around twice as potent as the lower flowers.
Article

Californian Cannabis Industry Hit by Wildfires

In addition to losses from direct burning as wildfires spread, soot is holding back plant growth whilst fire-borne contaminants continue to pose a risk to consumers.
Article

British Government Set to Loosen Rules on Medicinal Cannabis

The changes concern the reclassification of cannabis to make it a schedule 2 drug, allowing it to be prescribed by medical professionals and possessed lawfully by anybody with a valid medical prescription.
Advertisement